Gomez et al., 2021 - Google Patents
Sex differences in COVID-19 hospitalization and mortalityGomez et al., 2021
View PDF- Document ID
- 14326264448827925422
- Author
- Gomez J
- Du-Fay-de-Lavallaz J
- Fugar S
- Sarau A
- Simmons J
- Clark B
- Sanghani R
- Aggarwal N
- Williams K
- Doukky R
- Volgman A
- Publication year
- Publication venue
- Journal of Women's health
External Links
Snippet
Background: To investigate sex differences in coronavirus disease 2019 (COVID-19) outcomes in a large Illinois-based cohort. Methods: A multicenter retrospective cohort study compared males versus females with COVID-19 infections from March 1, 2020, to June 21 …
- 200000000015 coronavirus disease 2019 0 title abstract description 84
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/328—Health insurance management, e.g. payments or protection against fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for programme control, e.g. control unit
- G06F9/06—Arrangements for programme control, e.g. control unit using stored programme, i.e. using internal store of processing equipment to receive and retain programme
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gomez et al. | Sex differences in COVID-19 hospitalization and mortality | |
Liu et al. | Risk factors for developing into critical COVID-19 patients in Wuhan, China: a multicenter, retrospective, cohort study | |
Chang et al. | Risk factors for disease progression in COVID-19 patients | |
Wang et al. | Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients | |
Hwang et al. | Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study | |
Steinberg et al. | In young adults with COVID-19, obesity is associated with adverse outcomes | |
Stepanova et al. | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity | |
Yeo et al. | Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19 | |
Butt et al. | Co‐morbid medical and psychiatric illness and substance abuse in HCV‐infected and uninfected veterans | |
Memon et al. | Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study | |
Lee et al. | Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia | |
Maripuu et al. | Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in Sweden during the early months of the outbreak—an exploratory cross-sectional analysis of a population-based register study | |
Zuccaro et al. | Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) | |
Ludwikowska et al. | Distinct characteristics of multisystem inflammatory syndrome in children in Poland | |
Chen et al. | Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study | |
Yang et al. | Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection | |
Bush et al. | Impact of hepatitis C virus and insurance coverage on mortality | |
Luan et al. | Increased risk of nasal septal abscess after septoplasty in patients with type 2 diabetes mellitus | |
Chong et al. | Association of viral hepatitis and bipolar disorder: a nationwide population-based study | |
Tsai et al. | COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans | |
Noorian et al. | The impact of NAFLD on hospitalization outcomes in patients with inflammatory bowel diseases: nationwide analysis | |
Pham et al. | Sustained virologic response and costs associated with direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid | |
Zhang et al. | Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China | |
Christiansen et al. | Type 2 diabetes and 1‐year mortality in intensive care unit patients | |
Sung et al. | Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis |